Scientists have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool is ...
Researchers have created a platform, called SIMPL2, that revolutionizes the study of protein-protein interactions by simplifying detection while improving measurement accuracy. While protein-protein ...
Exploring the biomedical interactions about chemical compounds and protein targets is crucial for drug discovery. Determining these interactions (DDI/DTI) not only reveals the potential synergistic ...
In the early 1980s, David Gilmour, now an emeritus biochemistry and molecular biology professor at Pennsylvania State University, joined the laboratory of geneticist and biochemist John Lis as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback